CHC
MDGL icon

City Holding Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

City Holding Co’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Hold
40
– – ﹤0.01% 441
2026
Q1 		$20.9K Hold
40
– – ﹤0.01% 402
2025
Q4 		$23.3K Buy
+40
New +$20.4K ﹤0.01% 405

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

City Holding Co's MDGL Position: Q2 2026 in Review

City Holding Co held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 40 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

City Holding Co first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.3K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • City Holding Co held 40 shares of Madrigal Pharmaceuticals worth $21.5K as of Q2 2026.
  • City Holding Co left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of City Holding Co's portfolio in Q2 2026, its #441 holding.
  • City Holding Co first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • City Holding Co's Madrigal Pharmaceuticals position peaked at $23.3K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.